Logo image of A

AGILENT TECHNOLOGIES INC (A) Stock Overview

USA - NYSE:A - US00846U1016 - Common Stock

144.78 USD
-1.07 (-0.73%)
Last: 10/29/2025, 11:37:42 AM

A Key Statistics, Chart & Performance

Key Statistics
Market Cap41.05B
Revenue(TTM)6.79B
Net Income(TTM)1.22B
Shares283.50M
Float282.61M
52 Week High153.84
52 Week Low96.43
Yearly Dividend0.95
Dividend Yield0.67%
EPS(TTM)5.45
PE26.57
Fwd PE23.6
Earnings (Next)11-24 2025-11-24/amc
IPO1999-11-18
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


A short term performance overview.The bars show the price performance of A in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

A long term performance overview.The bars show the price performance of A in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of A is 144.78 USD. In the past month the price increased by 13.63%. In the past year, price increased by 6.56%.

AGILENT TECHNOLOGIES INC / A Daily stock chart

A Latest News, Press Relases and Analysis

A Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.2 213.14B
DHR DANAHER CORP 28.11 155.19B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 143.51 46.81B
IQV IQVIA HOLDINGS INC 18.88 37.33B
MTD METTLER-TOLEDO INTERNATIONAL 34.22 28.83B
WAT WATERS CORP 28.26 20.57B
WST WEST PHARMACEUTICAL SERVICES 40.47 20.58B
MEDP MEDPACE HOLDINGS INC 40.97 16.46B
TEM TEMPUS AI INC N/A 15.31B
ILMN ILLUMINA INC 23.45 15.00B
ICLR ICON PLC 13.05 13.39B
RVTY REVVITY INC 20.12 11.19B

About A

Company Profile

A logo image Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

Company Info

AGILENT TECHNOLOGIES INC

5301 Stevens Creek Blvd

Santa Clara CALIFORNIA 95051 US

CEO: Michael R. McMullen

Employees: 18000

A Company Website

A Investor Relations

Phone: 14083458886

AGILENT TECHNOLOGIES INC / A FAQ

Can you describe the business of AGILENT TECHNOLOGIES INC?

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.


What is the stock price of AGILENT TECHNOLOGIES INC today?

The current stock price of A is 144.78 USD. The price decreased by -0.73% in the last trading session.


What is the dividend status of AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a dividend yield of 0.67%. The yearly dividend amount is currently 0.95.


What is the ChartMill technical and fundamental rating of A stock?

A has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is A stock listed?

A stock is listed on the New York Stock Exchange, Inc. exchange.


What do analysts say about AGILENT TECHNOLOGIES INC (A) stock?

26 analysts have analysed A and the average price target is 140.65 USD. This implies a price decrease of -2.85% is expected in the next year compared to the current price of 144.78.


How is the valuation of AGILENT TECHNOLOGIES INC (A) based on its PE ratio?

The PE ratio for AGILENT TECHNOLOGIES INC (A) is 26.57. This is based on the reported non-GAAP earnings per share of 5.45 and the current share price of 144.78 USD.


A Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to A. When comparing the yearly performance of all stocks, A is one of the better performing stocks in the market, outperforming 75.18% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

A Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to A. A has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

A Financial Highlights

Over the last trailing twelve months A reported a non-GAAP Earnings per Share(EPS) of 5.45. The EPS increased by 4.61% compared to the year before.


Industry RankSector Rank
PM (TTM) 17.97%
ROA 9.98%
ROE 19.15%
Debt/Equity 0.54
Chartmill High Growth Momentum
EPS Q2Q%3.79%
Sales Q2Q%10.14%
EPS 1Y (TTM)4.61%
Revenue 1Y (TTM)4.48%

A Forecast & Estimates

26 analysts have analysed A and the average price target is 140.65 USD. This implies a price decrease of -2.85% is expected in the next year compared to the current price of 144.78.

For the next year, analysts expect an EPS growth of 7.48% and a revenue growth 6.72% for A


Analysts
Analysts75.38
Price Target140.65 (-2.85%)
EPS Next Y7.48%
Revenue Next Year6.72%

A Ownership

Ownership
Inst Owners92.27%
Ins Owners0.13%
Short Float %1.2%
Short Ratio1.95